Hepatology (ICH-27)

This track focuses on the latest findings and methodologies in hepatology research, including basic science and translational studies. It aims to foster collaboration among researchers to enhance understanding of liver diseases.

This session will explore the pathophysiology, diagnosis, and management of autoimmune and genetic liver diseases. Participants will discuss recent advancements in genetic research and their implications for clinical practice.

This track addresses the complexities of managing hepatitis B, C, D, and E, highlighting innovative treatment strategies and public health approaches. Experts will share insights into the epidemiology and prevention of viral hepatitis.

This session will delve into the complications associated with liver cirrhosis, including portal hypertension and hepatic encephalopathy. Discussions will focus on current management strategies and emerging therapies.

This track examines the etiology, diagnosis, and treatment of alcoholic liver disease and non-alcoholic fatty liver disease. Participants will discuss lifestyle interventions and pharmacological options for management.

This session will cover the latest diagnostic techniques and treatment modalities for hepatocellular carcinoma. Experts will present data on surgical, medical, and interventional approaches to improve patient outcomes.

This track focuses on the unique aspects of liver disease in pediatric populations, including congenital disorders and acquired liver diseases. Discussions will emphasize the importance of early diagnosis and tailored treatment strategies.

This session will explore advancements in liver transplantation, including donor selection, surgical techniques, and post-operative care. Participants will discuss outcomes and the role of transplantation in end-stage liver disease.

This track highlights the role of endoscopic retrograde cholangiopancreatography (ERCP) and other interventional techniques in the management of liver and biliary disorders. Case studies and recent advancements will be presented.

This session will address the role of public health initiatives in preventing and managing liver diseases. Participants will discuss strategies for community engagement, education, and policy development.

This track will focus on novel therapeutic agents and innovative approaches in the treatment of liver diseases. Experts will discuss ongoing clinical trials and the future landscape of hepatology.